Jeffrey Weinberg, MD: Psoriasis Duration Doesn’t Impact Brodalumab Success

Brodalumab mode of actionПодробнее

[8 Surprising Symptoms] of Psoriasis: Physician Expert Explains What Not to MissПодробнее

Brodalumab - Siliq - In a nutshell.Подробнее

Leon Kircik, MD - What differentiates Siliq from other IL-17 biologics?Подробнее

Experimental Treatment for Psoriasis Shows PromiseПодробнее

Scalp Psoriasis: What NOT To Do #shortsПодробнее

David M. Pariser, MD - An Economic Evaluation of The Budget Impact of Precision Medicine Testing...Подробнее

2 TIps to Cure Psoriasis and Eczema #shortsПодробнее

Clinical Pearls for Topical Therapies in Psoriasis by Dr. Linda Stein GoldПодробнее

Mark Lebwohl, MD - Apremilast as an Off-Label Therapeutic AgentПодробнее

3 Natural Approaches to Improving PsoriasisПодробнее

What role can genetics play in future psoriasis treatment? - Professor Jonathan BarkerПодробнее

Dr Steven Feldman on Managing Psoriasis in Patients With Metabolic SyndromeПодробнее

The Evolution of Modern Psoriasis Management - Dermatology Update 2016Подробнее

Psoriasis down the ages - a historical review of a common skin conditionПодробнее

Progressing the Future of Care for People Living with PsoriasisПодробнее

Dr Steven R. Feldman on the Effect of Metabolic Syndrome on Treatments for PsoriasisПодробнее

Psoriasis Patient Shares Science of Skin 2024 ExperienceПодробнее

Week 4 of Siliq! | November 2020 | Breaking the Puzzle | Weaver PresentationsПодробнее